Accelerate Diagnostics Inc reports results for the quarter ended in June - Earnings Summary

Accelerate Diagnostics

05/08/2021 23:33

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of 36 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 33 cents per share.
* Revenue rose 31.7% to $2.80 million from a year ago;  analysts
expected $3.07 million. 
* The mean earnings estimate of analysts had fallen by
about 1.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Accelerate Diagnostics Inc shares had fallen by 14.0% this
quarter and lost 8.6% so far this year.
* Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $13.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated August 5 at 10:33 p.m.  ​All
figures in US dollars unless otherwise stated